Longeveron Stock (NASDAQ:LGVN), Trade Ideas

Longeveron

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Earnings

News

Penny Stocks

Eurozone

Commodities

Small Cap

Global

Intraday Update

Markets

Trading Ideas

LGVN

MRNS

NMRA

RARE

SNGX

SNPO

U.S. stocks turned lower toward the end of trading, with the S&amp;P 500 falling more than 1% on Monday.

The Dow traded down 0.64% to 37,741.18 while the NASDAQ fell 1.68% to 15,902.96. The S&amp;P 500 also fell, dropping, 1.14% to 5,065.04.

S&amp;P 500 Down Over 1%; US Retail Sales Increase 0.7% In March

Movers

ADIL

AEYE

Alterity Therapeutics Limited - American Depositary Shares

ATHE

BHVN

BTCY

CENX

CMAX

Envoy Medical, Inc. - Class A Common Stock

COCH

DXYZ

EGIO

EXTR

HUBC

IMCC

INFA

KAVL

KUKE

LOCL

MNDR

Nuveen California Dividend Advantage Municipal Fund 2

NXPL

ONVO

PROK

PSNY

QTTB

RENT

SPCB

SPWR

SRFM

SWVL

TCON

VERU

VIAO

WIRE

Shares of  Ultragenyx Pharmaceutical Inc.  (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

SCHW

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Monday.

The Dow traded up 0.35% to 38,114.61 while the NASDAQ rose 0.07% to 16,187.02. The S&amp;P 500 also rose, gaining, 0.26% to 5,136.94.

Crude Oil Down 1%; Charles Schwab Sales Top Estimates

Longeveron Inc

Price Target

Analyst Ratings

Watching Longeveron Shares; Zacks Small-Cap Research Sets $15.15 Valuation

<h3>Gainers</h3>
<ul>
<li>Dynatronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYNT#NASDAQ">DYNT</a>) stock increased by 70.1% to $0.63 during Monday's after-market session. The company's market cap stands at $3.0 million. </li>
<li>Cardio Diagnostics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDIO#NASDAQ">CDIO</a>) stock rose 14.28% to $1.14. The company's market cap stands at $24.6 million. </li>
<li>Aptorum Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APM#NASDAQ">APM</a>) shares rose 12.61% to $8.84. The market value of their outstanding shares is at $45.8 million. </li>
<li>Cue Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLTH#NASDAQ">HLTH</a>) shares moved upwards by 8.76% to $0.16. The company's market cap stands at $25.9 million. </li>
<li>P3 Health Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIII#NASDAQ">PIII</a>) shares increased by 8.37% to $0.53. The company's market cap stands at $63.7 million. </li>
<li>BioVie (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIVI#NASDAQ">BIVI</a>) shares rose 7.87% to $0.53. The market value of their outstanding shares is at $29.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Poseida Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTX#NASDAQ">PSTX</a>) shares declined by 15.2% to $2.06 during Monday's after-market session. The market value of their outstanding shares is at $198.7 million. </li>
<li>Alterity Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATHE#NASDAQ">ATHE</a>) shares fell 6.94% to $2.28. The market value of their outstanding shares is at $19.9 million. </li>
<li>Jaguar Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) shares fell 6.74% to $0.11. The company's market cap stands at $30.6 million. </li>
<li>Yield10 Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YTEN#NASDAQ">YTEN</a>) stock decreased by 6.4% to $0.26. The company's market cap stands at $4.0 million. </li>
<li>Qilian Intl Hldg Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QLI#NASDAQ">QLI</a>) shares declined by 6.26% to $0.65. The market value of their outstanding shares is at $23.2 million. </li>
<li>Longeveron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGVN#NASDAQ">LGVN</a>) stock declined by 5.81% to $2.76. The market value of their outstanding shares is at $8.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BIVI

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

DYNT

HLTH

JAGX

PIII

PSTX

YTEN

12 Health Care Stocks Moving In Monday's After-Market Session

U.S. stocks turned lower toward the end of trading, with the S&amp;P 500 falling more than 1% on Monday.
The Dow traded down 0.64% to 37,741.18 while the NASDAQ fell 1.68% to 15,902.96. The S&amp;P 500 also fell, dropping, 1.14% to 5,065.04.
Check This Out: <a href="https://www.benzinga.com/news/24/04/38218786/best-buy-box-and-2-other-stocks-insiders-are-selling"> Best Buy, Box And 2 Other Stocks Insiders Are Selling </a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Health care shares rose by 0.01% on Friday.
In trading on Friday, information technology shares fell by 1.8%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
U.S. retail sales increased 0.7% month-over-month in March following a revised 0.9% rise in February.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
Soligenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sngx#NASDAQ">SNGX</a>) shares shot up 34% to $0.5197 after the company announced that it was granted orphan drug designation to the active ingredient in MarVax for the prevention and post-exposure prophylaxis against MARV infection by the FDA.
Shares of Longeveron Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgvn#NASDAQ">LGVN</a>) got a boost, surging 58% to $2.6750 following insider buys from multiple company executives.
Snap One Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snpo#NASDAQ">SNPO</a>) shares were also up, gaining 30% to $10.60 after the company announced that it will be acquired by Resideo Technologies.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Marinus Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrns#NASDAQ">MRNS</a>) shares dropped 81% to $1.4250 after the company provided an update on the Phase 3 RAISE trial and reported preliminary first-quarter financial results.
Shares of Neumora Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmra#NASDAQ">NMRA</a>) were down 11% to $12.02 after the FDA placed a clinical hold on the company&#39;s Phase 1 NMRA-266 study.
Ultragenyx Pharmaceutical Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rare#NASDAQ">RARE</a>) was down, falling 10% to $42.73 after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.
Also Check This Out:<a href="https://www.benzinga.com/news/24/04/38246593/wall-streets-most-accurate-analysts-views-on-3-tech-stocks-with-over-4-dividend-yields"> Wall Street&#39;s Most Accurate Analysts&#39; Views On 3 Tech Stocks With Over 4% Dividend Yields </a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded down 0.6% to $85.17 while gold traded up 0.3% at $2,381.50.
Silver traded up 1.6% to $28.795 on Friday, while copper rose 2.3% to $4.3575.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares closed mostly higher today. The eurozone&rsquo;s STOXX 600 rose 0.13%, London&rsquo;s FTSE 100 fell 0.38% while Spain&rsquo;s IBEX 35 Index rose 0.01% The German DAX gained 0.54% French CAC 40 climbed 0.43% while Italy&rsquo;s FTSE MIB Index jumped 0.56%.
Industrial production in the eurozone increased by 0.8% month-over-month in February.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mostly lower on Monday, with Japan&rsquo;s Nikkei 225 falling 0.74%, Hong Kong&rsquo;s Hang Seng Index dropping 0.72%, China&rsquo;s Shanghai Composite gaining 1.26% and India&rsquo;s S&amp;P BSE Sensex dipping 1.14%.
Indian merchandise trade deficit shrank to $15.6 billion in March versus a year-ago gap of $18.1 billion, while wholesale prices rose by 0.53% year-over-year in March versus a 0.20% gain in the prior month.
&nbsp;
<h3>Economics</h3>
&nbsp;
The NY Empire State Manufacturing Index climbed to -14.3 in April versus prior month&rsquo;s reading of -20.9.
Retail sales increased 0.7% month-over-month in March following a revised 0.9% rise in February.
The NAHB/Wells Fargo Housing Market Index in came in unchanged at 51.0 in April.
Total business inventories increased by 0.4% month-over-month in February, versus market expectations of a 0.3% rise.
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38248683/bitcoin-surpasses-66-000-core-emerges-as-top-gainer"> Bitcoin Surpasses $66,000; Core Emerges As Top Gainer </a>
&nbsp;

S&P 500 Down Over 1%; US Retail Sales Increase 0.7% In March

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rare#NASDAQ">RARE</a>) fell sharply during Monday&rsquo;s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.
Ultragenyx Pharmaceutical shares dipped 9.4% to $42.46 on Monday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Soligenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sngx#NASDAQ">SNGX</a>) shares surged 71.5% to $0.6679 after the company announced that it was granted orphan drug designation to the active ingredient in MarVax for the prevention and post-exposure prophylaxis against MARV infection by the FDA.</li>
<li>Longeveron Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgvn#NASDAQ">LGVN</a>) surged 54% to $2.6350 following insider buys from multiple company executives.</li>
<li>SuperCom Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spcb#NASDAQ">SPCB</a>) shares gained 39.4% to $0.3849 after jumping around 18% on Friday.</li>
<li>Piedmont Lithium Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pll#NYSE">PLL</a>) shares gained 32.1% to $16.75 following a 5% decline on Friday.</li>
<li>Snap One Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snpo#NASDAQ">SNPO</a>) surged 31.6% to $10.71 after the company announced that it will be acquired by Resideo Technologies.</li>
<li>Organovo Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/onvo#NASDAQ">ONVO</a>) shares surged 30.9% to $1.32 after the company announced Phase 2 results for FXR314. Study results demonstrated statistically significant reduction in liver fat content from baseline in patients receiving FXR314 compared to placebo.</li>
<li>Kuke Music Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kuke#NASDAQ">KUKE</a>) jumped 27% to $2.7650.</li>
<li>HUB Cyber Security Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hubc#NASDAQ">HUBC</a>) gained 24% to $1.61 after gaining over 11% on Friday.</li>
<li>Edgio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/egio#NASDAQ">EGIO</a>) gained 24% to $22.18.</li>
<li>Kaival Brands Innovations Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kavl#NASDAQ">KAVL</a>) surged 23.6% to $3.30.</li>
<li>Envoy Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coch#NASDAQ">COCH</a>) gained 22.6% to $6.19.</li>
<li>Medical Properties Trust, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mpw#NYSE">MPW</a>) rose 19.9% to $4.7850 after the company announced that it sold its majority interest in Utah Hospitals.</li>
<li>CareMax, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmax#NASDAQ">CMAX</a>) climbed 19.5% to $3.78.</li>
<li>SES AI Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ses#NYSE">SES</a>) surged 18.7% to $1.77.</li>
<li>Mobile-health Network Solutions (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mndr#NASDAQ">MNDR</a>) gained 17.7% to $17.67.</li>
<li>Adial Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adil#NASDAQ">ADIL</a>) rose 16.7% to $2.72.</li>
<li>ProKidney Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prok#NASDAQ">PROK</a>) gained 16.7% to $2.0426.</li>
<li>Biotricity, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btcy#NASDAQ">BTCY</a>) rose 16.5% to $1.34.</li>
<li>Yatsen Holding Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ysg#NYSE">YSG</a>) gained 13.3% to $3.41.</li>
<li>Destiny Tech100 Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dxyz#NASDAQ">DXYZ</a>) shares gained 12.8% to $32.71 after dipping 42% on Friday.</li>
<li>Encore Wire Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wire#NASDAQ">WIRE</a>) surged 11.7% to $291.60 after the company entered an agreement to be acquired by Prysmian for $290 per share in cash.</li>
<li>Century Aluminum Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cenx#NASDAQ">CENX</a>) gained 9.5% to $18.05.</li>
<li>Extreme Networks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/extr#NASDAQ">EXTR</a>) gained 5.7% to $11.31. B. Riley Securities analyst Dave Kang upgraded Extreme Networks from Neutral to Buy and maintained a $14 price target.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Marinus Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrns#NASDAQ">MRNS</a>) shares dipped 77% to $1.6800 after the company provided an update on the Phase 3 RAISE trial and reported preliminary Q1 financial results.</li>
<li>Swvl Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swvl#NASDAQ">SWVL</a>) fell 35% to $8.58.</li>
<li>VIA optronics AG (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/viao#NASDAQ">VIAO</a>) dipped 34% to $0.2765.</li>
<li>Veru Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/veru#NASDAQ">VERU</a>) fell 24% to $1.1550. Oppenheimer analyst Leland Gershell reiterated Veru with an Outperform and lowered the price target from $7 to $5.</li>
<li>Rent the Runway, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rent#NASDAQ">RENT</a>) dipped 19.8% to $15.42.</li>
<li>NextPlat Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxpl#NASDAQ">NXPL</a>) fell 19.8% to $1.50 after jumping 24% on Friday. The company entered into a definitive business combination agreement with its majority-owned subsidiary Progressive Care Inc.</li>
<li>Cyngn Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyn#NASDAQ">CYN</a>) shares fell 19.1% to $0.1170 after declining around 7% on Friday.</li>
<li>ProMIS Neurosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pmn#NASDAQ">PMN</a>) fell 15.6% to $1.95.</li>
<li>Biohaven Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bhvn#NASDAQ">BHVN</a>) dipped 15.4% to $44.90. Biohaven showcased innovative neuroscience portfolio with 20 presentations at the 2024 AAN Annual Meeting.</li>
<li>Neumora Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmra#NASDAQ">NMRA</a>) shares declined 15.1% to $11.48 after the FDA placed a clinical hold on the company&#39;s Phase 1 NMRA-266 study.</li>
<li>Alterity Therapeutics Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/athe#NASDAQ">ATHE</a>) dipped 15% to $2.49.</li>
<li>Surf Air Mobility Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srfm#NASDAQ">SRFM</a>) fell 15% to $0.53.</li>
<li>IM Cannabis Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imcc#NASDAQ">IMCC</a>) fell 14.2% to $0.5399.</li>
<li>Polestar Automotive Holding Uk Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/psny#NASDAQ">PSNY</a>) fell 12.7% to $1.2699. On Friday, Cantor Fitzgerald analyst Andres Sheppard reiterated Polestar Automotive with an Overweight and maintained a $5 price target.</li>
<li>Desktop Metal, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dm#NYSE">DM</a>) fell 10.8% to $0.8510.</li>
<li>Local Bounti Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/locl#NYSE">LOCL</a>) declined 10.2% to $2.1550.</li>
<li>Q32 Bio Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qttb#NASDAQ">QTTB</a>) fell 10% to $26.00.</li>
<li>SunPower Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spwr#NASDAQ">SPWR</a>) fell 8.3% to $2.2750.</li>
<li>Informatica Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/infa#NASDAQ">INFA</a>) dipped 8.1% to $35.36 amid increased volatility following reports suggesting Salesforce is in talks to buy the company.</li>
<li>TRACON Pharmaceuticals Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcon#NASDAQ">TCON</a>) declined 8.1% to $2.1699 after falling around 9% on Friday.</li>
<li>NOVONIX Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nvx#NYSE">NVX</a>) declined 7.2% to $2.63.</li>
<li>AudioEye, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aeye#NASDAQ">AEYE</a>) fell 6.6% to $12.86 after declining around 7% on Friday.</li>
<li>OncoCyte Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocx#NASDAQ">OCX</a>) fell 6.6% to $2.5301. Oncocyte announced a transplant assay partnership agreement with Bio-Rad laboratories.</li>
<li>BlackBerry Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bb#NYSE">BB</a>) fell 6.1% to $2.8650.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38249138/dow-jumps-over-300-points-goldman-sachs-posts-upbeat-earnings"> Dow Jumps Over 300 Points; Goldman Sachs Posts Upbeat Earnings</a>

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>Longeveron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGVN#NASDAQ">LGVN</a>) stock moved upwards by 44.4% to $2.44 during Monday's regular session. The market value of their outstanding shares is at $7.7 million. </li>
<li>Mobile-health Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDR#NASDAQ">MNDR</a>) shares rose 35.53% to $20.33. The company's market cap stands at $691.2 million. </li>
<li>Jaguar Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) shares moved upwards by 31.89% to $0.12. The company's market cap stands at $32.8 million. </li>
<li>Soligenix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) stock increased by 30.35% to $0.5. The market value of their outstanding shares is at $5.2 million. </li>
<li>ProKidney (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROK#NASDAQ">PROK</a>) stock increased by 26.33% to $2.21. The company's market cap stands at $136.2 million. </li>
<li>Organovo Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONVO#NASDAQ">ONVO</a>) shares moved upwards by 24.58% to $1.26. The market value of their outstanding shares is at $12.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Marinus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNS#NASDAQ">MRNS</a>) shares fell 79.8% to $1.52 during Monday's regular session. The market value of their outstanding shares is at $83.4 million. </li>
<li>Alterity Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATHE#NASDAQ">ATHE</a>) stock decreased by 20.07% to $2.35. The company's market cap stands at $20.5 million. </li>
<li>BioSig Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSGM#NASDAQ">BSGM</a>) stock decreased by 18.76% to $1.1. The market value of their outstanding shares is at $10.3 million. </li>
<li>Rallybio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RLYB#NASDAQ">RLYB</a>) shares fell 18.16% to $1.8. The market value of their outstanding shares is at $74.6 million. </li>
<li>MSP Recovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIFW#NASDAQ">LIFW</a>) stock fell 17.42% to $0.94. The market value of their outstanding shares is at $13.9 million. As per the news, the Q4 earnings report came out today. </li>
<li>China SXT Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTC#NASDAQ">SXTC</a>) stock declined by 17.15% to $1.16. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BSGM

LIFW

RLYB

SXTC

12 Health Care Stocks Moving In Monday's Intraday Session

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Monday.
The Dow traded up 0.35% to 38,114.61 while the NASDAQ rose 0.07% to 16,187.02. The S&amp;P 500 also rose, gaining, 0.26% to 5,136.94.
Check This Out: <a href="https://www.benzinga.com/news/24/04/38218786/best-buy-box-and-2-other-stocks-insiders-are-selling"> Best Buy, Box And 2 Other Stocks Insiders Are Selling </a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Health care shares jumped by 0.7% on Friday.
In trading on Friday, real estate shares fell by 1.1%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
Charles Schwab Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/schw#NYSE">SCHW</a>) reported better-than-expected first-quarter earnings on Monday.
Charles Schwab reported a first-quarter 2024 adjusted net income decline of 17% Y/Y to $1.469 billion. Adjusted EPS fell 20% Y/Y to 74 cents, which came in line with the consensus. Revenue fell 7% to $4.74 billion, marginally beating the consensus of $4.71 billion.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
Soligenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sngx#NASDAQ">SNGX</a>) shares shot up 49% to $0.5802 after the company announced that it was granted orphan drug designation to the active ingredient in MarVax for the prevention and post-exposure prophylaxis against MARV infection by the FDA.
Shares of Longeveron Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgvn#NASDAQ">LGVN</a>) got a boost, surging 52% to $2.5650 following insider buys from multiple company executives.
Snap One Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snpo#NASDAQ">SNPO</a>) shares were also up, gaining 30% to $10.61 after the company announced that it will be acquired by Resideo Technologies.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Marinus Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrns#NASDAQ">MRNS</a>) shares dropped 79% to $1.5792 after the company provided an update on the Phase 3 RAISE trial and reported preliminary first-quarter financial results.
Shares of Neumora Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmra#NASDAQ">NMRA</a>) were down 14% to $11.67 after the FDA placed a clinical hold on the company&#39;s Phase 1 NMRA-266 study.
Ultragenyx Pharmaceutical Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rare#NASDAQ">RARE</a>) was down, falling 10% to $42.46 after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.
Also Check This Out:<a href="https://www.benzinga.com/news/24/04/38246593/wall-streets-most-accurate-analysts-views-on-3-tech-stocks-with-over-4-dividend-yields"> Wall Street&#39;s Most Accurate Analysts&#39; Views On 3 Tech Stocks With Over 4% Dividend Yields </a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded down 1.3% to $84.55 while gold traded down 0.5% at $2,362.00.
Silver traded up 0.8% to $28.55 on Friday, while copper rose 1.7% to $4.3315.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares were mostly higher today. The eurozone&rsquo;s STOXX 600 rose 0.06%, London&rsquo;s FTSE 100 fell 0.48% while Spain&rsquo;s IBEX 35 Index fell 0.11% The German DAX gained 0.39% French CAC 40 climbed 0.31% while Italy&rsquo;s FTSE MIB Index jumped 0.45%.
Industrial production in the eurozone increased by 0.8% month-over-month in February.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mostly lower on Monday, with Japan&rsquo;s Nikkei 225 falling 0.74%, Hong Kong&rsquo;s Hang Seng Index dropping 0.72%, China&rsquo;s Shanghai Composite gaining 1.26% and India&rsquo;s S&amp;P BSE Sensex dipping 1.14%.
Indian merchandise trade deficit shrank to $15.6 billion in March versus a year-ago gap of $18.1 billion, while wholesale prices rose by 0.53% year-over-year in March versus a 0.20% gain in the prior month.
&nbsp;
<h3>Economics</h3>
&nbsp;
The NY Empire State Manufacturing Index climbed to -14.3 in April versus prior month&rsquo;s reading of -20.9.
Retail sales increased 0.7% month-over-month in March following a revised 0.9% rise in February.
The NAHB/Wells Fargo Housing Market Index in came in unchanged at 51.0 in April.
Total business inventories increased by 0.4% month-over-month in February, versus market expectations of a 0.3% rise.
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38248683/bitcoin-surpasses-66-000-core-emerges-as-top-gainer"> Bitcoin Surpasses $66,000; Core Emerges As Top Gainer </a>

Longeveron Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGVN#NASDAQ">LGVN</a>) shares are trading higher Monday following insider buys from multiple company executives. Here's a <a href="https://www.benzinga.com/news/earnings/24/04/38249138/dow-jumps-over-300-points-goldman-sachs-posts-upbeat-earnings">look at what's going on</a>.
What To Know:
Multiple company executives disclosed large stock purchases after the close on Friday. Joshua Hare, Chief Scientific Officer, purchased 297,872 shares. Rock Soffer, director, purchased 276,596 shares and CEO Mohamed Wa&#8217;el Ahmed Hashad purchased 21,276 shares.&nbsp;
Longeveron<a href="https://www.benzinga.com/pressreleases/24/04/g38212699/longeveron-announces-closing-of-5-2-million-public-offering"> announced </a>the closing of its public offering last week with proceeds of approximately $5.2 million. The company intends to use the net proceeds from the offering for its ongoing clinical and regulatory development of Lomecel-B for the treatment of several disease states and indications, including HLHS and Alzheimer&#8217;s disease, obtaining regulatory approvals, capital expenditures, working capital and other general corporate purposes.
Related News: <a href="https://www.benzinga.com/news/24/04/38227765/whats-going-on-with-palantir-stock">What&#8217;s Going On With Palantir Stock?</a>
<h2 class="wp-block-heading">Should I Sell My LGVN Stock?</h2>
Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.
Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.
Shares of Longeveron have lost 91.16% year to date. This compares to the average annual return of -71.29%, meaning the stock has under-performed its historical averages. Investors can compare a stock's movement to its historical performance to gauge whether this is a normal movement or a potential trading opportunity. 
Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Longeveron stock currently has an RSI of 15.75, indicating oversold conditions.
For analysis tools, charting data and access to exclusive stock news, check out <a href="https://pro.benzinga.com/">Benzinga PRO. Try it for free.</a> 
LGVN Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Longeveron shares are up 50.3% at $2.54 at the time of publication Monday.
Image: PublicDomainPictures from Pixabay

What's Going On With Longeveron Stock?

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 300 points on Monday.
The Dow traded up 0.89% to 38,321.05 while the NASDAQ rose 0.70% to 16,288.03. The S&amp;P 500 also rose, gaining, 0.80% to 5,164.30.
Check This Out: <a href="https://www.benzinga.com/news/24/04/38218786/best-buy-box-and-2-other-stocks-insiders-are-selling"> Best Buy, Box And 2 Other Stocks Insiders Are Selling </a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Financial shares jumped by 1.5% on Friday.
In trading on Friday, real estate shares rose by just 0.3%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
Goldman Sachs Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gs#NYSE">GS</a>) reported better-than-expected first-quarter earnings on Monday.
Goldman Sachs reported revenue of $14.21 billion for the first quarter of 2024, beating the consensus of $12.92 billion. The U.S. financial services giant reported EPS of $11.58, beating the consensus of $8.60.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
Soligenix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sngx#NASDAQ">SNGX</a>) shares shot up 98% to $0.7699 after the company announced that it was granted orphan drug designation to the active ingredient in MarVax for the prevention and post-exposure prophylaxis against MARV infection by the FDA.
Shares of Longeveron Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgvn#NASDAQ">LGVN</a>) got a boost, surging 70% to $2.87 following insider buys from multiple company executives.
Organovo Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/onvo#NASDAQ">ONVO</a>) shares were also up, gaining 23% to $1.2613 after the company announced Phase 2 results for FXR314. Study results demonstrated statistically significant reduction in liver fat content from baseline in patients receiving FXR314 compared to placebo.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Marinus Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrns#NASDAQ">MRNS</a>) shares dropped 76% to $1.7680 after the company provided an update on the Phase 3 RAISE trial and reported preliminary Q1 financial results.
Shares of ProMIS Neurosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pmn#NASDAQ">PMN</a>) were down 29% to $1.63.
PaxMedica, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pxmd#NASDAQ">PXMD</a>) was down, falling 23% to $0.6501. PaxMedica, last week, announced the completed execution of three pivotal registration/validation batches of PAX-101.
Also Check This Out:<a href="https://www.benzinga.com/news/24/04/38246593/wall-streets-most-accurate-analysts-views-on-3-tech-stocks-with-over-4-dividend-yields"> Wall Street&#39;s Most Accurate Analysts&#39; Views On 3 Tech Stocks With Over 4% Dividend Yields </a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded up 0.5% to $85.43 while gold traded down 0.8% at $2,353.50.
Silver traded down 0.6% to $28.075 on Friday, while copper rose 0.1% to $4.2580.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares were higher today. The eurozone&rsquo;s STOXX 600 rose 0.8%, London&rsquo;s FTSE 100 gained 0.1% while Spain&rsquo;s IBEX 35 Index rose 0.6% The German DAX gained 1.4% French CAC 40 climbed 1.3% while Italy&rsquo;s FTSE MIB Index jumped 1.5%.
Industrial production in the eurozone increased by 0.8% month-over-month in February.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mostly lower on Monday, with Japan&rsquo;s Nikkei 225 falling 0.74%, Hong Kong&rsquo;s Hang Seng Index dropping 0.72%, China&rsquo;s Shanghai Composite gaining 1.26% and India&rsquo;s S&amp;P BSE Sensex dipping 1.14%.
Indian merchandise trade deficit shrank to $15.6 billion in March versus a year-ago gap of $18.1 billion, while wholesale prices rose by 0.53% year-over-year in March versus a 0.20% gain in the prior month.
&nbsp;
<h3>Economics</h3>
&nbsp;
The NY Empire State Manufacturing Index climbed to -14.3 in April versus prior month&rsquo;s reading of -20.9.
Retail sales increased 0.7% month-over-month in March following a revised 0.9% rise in February.
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38248683/bitcoin-surpasses-66-000-core-emerges-as-top-gainer"> Bitcoin Surpasses $66,000; Core Emerges As Top Gainer </a>

PXMD

Dow Jumps Over 300 Points; Goldman Sachs Posts Upbeat Earnings

WIIM

Longeveron shares are trading higher following insider buys from multiple company executives.

Insider Trades

Director, Chief Scientific Officer Joshua Hare Of Longeveron Reported Purchase On Friday Of 297,872 Shares At Average Price Of $1.24

Director Rock Soffer Of Longeveron Reported Purchase On Friday Of 276,596 Shares At Average Price Of $1.24

CEO Mohamed Wa'el Ahmed Hashad Of Longeveron Reported Purchase On Friday Of 21,276 Shares At Average Price Of $1.24

GS: 4.5% &#x7C;&nbsp;<a href="https://www.benzinga.com//node/38245445">Goldman Sachs shares are trading higher after the company reported better-than-expected Q1 EPS and revenues.</a>
LGVN: 82% &#x7C;&nbsp;<a href="https://www.benzinga.com//node/38246876">Longeveron&#39;s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B In Mild Alzheimer&#39;s Disease Accepted For Featured Research Session Oral Presentation At 2024 AAIC</a>
ONVO: 65% &#x7C;&nbsp;<a href="https://www.benzinga.com//node/38246185">Organovo Announces Phase 2 Results For FXR314; Says &#39;Study subjects receiving FXR314 achieved statistically significant reduction in liver fat content from baseline&#39;</a>

Market-Moving News for April 15th

Biotech

Events

General

Longeveron's CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B In Mild Alzheimer's Disease Accepted For Featured Research Session Oral Presentation At 2024 AAIC

<h3>Gainers</h3>
<ul>
<li>Soligenix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) stock increased by 95.1% to $0.75 during Monday's pre-market session. The company's market cap stands at $7.9 million. </li>
<li>Longeveron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGVN#NASDAQ">LGVN</a>) shares increased by 51.47% to $2.56. The company's market cap stands at $8.1 million. </li>
<li>Cartesian Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAC#NASDAQ">RNAC</a>) shares moved upwards by 40.02% to $27.15. The company's market cap stands at $482.7 million. </li>
<li>Biomerica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRA#NASDAQ">BMRA</a>) shares rose 21.98% to $1.01. The company's market cap stands at $16.9 million. As per the press release, Q3 earnings came out yesterday. </li>
<li>Allarity Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLR#NASDAQ">ALLR</a>) shares increased by 21.42% to $2.55. The company's market cap stands at $1.2 million. </li>
<li>Envoy Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COCH#NASDAQ">COCH</a>) stock moved upwards by 18.81% to $6.0. The company's market cap stands at $117.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Marinus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNS#NASDAQ">MRNS</a>) stock decreased by 74.5% to $1.92 during Monday's pre-market session. The market value of their outstanding shares is at $105.4 million. </li>
<li>TRACON Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCON#NASDAQ">TCON</a>) shares decreased by 17.8% to $1.94. The market value of their outstanding shares is at $4.4 million. </li>
<li>Neumora Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMRA#NASDAQ">NMRA</a>) shares declined by 17.04% to $11.25. The company's market cap stands at $1.7 billion. </li>
<li>PaxMedica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PXMD#NASDAQ">PXMD</a>) stock fell 16.57% to $0.7. The market value of their outstanding shares is at $5.1 million. </li>
<li>Alterity Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATHE#NASDAQ">ATHE</a>) stock fell 15.65% to $2.48. The market value of their outstanding shares is at $21.6 million. </li>
<li>SINTX Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SINT#NASDAQ">SINT</a>) shares decreased by 15.19% to $0.02. The market value of their outstanding shares is at $2.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALLR

BMRA

RNAC

SINT

12 Health Care Stocks Moving In Monday's Pre-Market Session

Shares of Medical Properties Trust, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mpw#NYSE">MPW</a>) rose sharply in today&rsquo;s pre-market trading after the company announced that it sold its majority <a href="https://www.benzinga.com/quote/MPW/news">interest in Utah Hospitals</a>.
Medical Properties Trust shares jumped 13.1% to $4.51 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3>Gainers</h3>
<ul>
<li>Allarity Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/allr#NASDAQ">ALLR</a>) shares rose 51% to $3.17 in pre-market trading after dipping 9% on Friday. Allarity Therapeutics filed prospectus supplement to increase offering price of common stock that may be offered from $2.35 million to $3.2 million.</li>
<li>Longeveron Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgvn#NASDAQ">LGVN</a>) gained 38.4% to $2.34 in pre-market trading after falling 16% on Friday. Longeveron, last week, announced closing of $5.2 million public offering.</li>
<li>SuperCom Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spcb#NASDAQ">SPCB</a>) shares gained 34.8% to $0.3722 in pre-market trading after jumping around 18% on Friday.</li>
<li>HUB Cyber Security Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hubc#NASDAQ">HUBC</a>) climbed 29.2% to $1.68 in pre-market trading after gaining over 11% on Friday.</li>
<li>Piedmont Lithium Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pll#NYSE">PLL</a>) shares gained 22.2% to $15.49 in pre-market trading following a 5% decline on Friday.</li>
<li>Marine Petroleum Trust (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/marps#NASDAQ">MARPS</a>) gained 12.3% to $6.04 in pre-market trading after jumping 18% on Friday.</li>
<li>Destiny Tech100 Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dxyz#NASDAQ">DXYZ</a>) shares gained 11.4% to $32.31 in pre-market trading after dipping 42% on Friday.</li>
<li>Kineta, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ka#NASDAQ">KA</a>) shares rose 8.7% to $0.3989 in pre-market trading after falling 17% on Friday.</li>
<li>LendingClub Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lc#NYSE">LC</a>) shares gained 8.7% to $8.79 in pre-market trading. LendingClub is expected to report earnings for the first quarter 2024 after the closing bell on Tuesday, April 30, 2024.</li>
</ul>
<h3>
Losers</h3>
<ul>
<li>AudioEye, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aeye#NASDAQ">AEYE</a>) fell 24.1% to $10.45 in pre-market trading after declining around 7% on Friday.</li>
<li>NextPlat Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxpl#NASDAQ">NXPL</a>) fell 19.8% to $1.50 in pre-market trading after jumping 24% on Friday. The company entered into a definitive business combination agreement with its majority-owned subsidiary Progressive Care Inc.</li>
<li>Organovo Holdings Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/onvo#NASDAQ">ONVO</a>) shares declined 15.8% to $0.85 in pre-market trading.</li>
<li>TRACON Pharmaceuticals Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcon#NASDAQ">TCON</a>) declined 15.3% to $2.00 in pre-market trading after falling around 9% on Friday.</li>
<li>IM Cannabis Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imcc#NASDAQ">IMCC</a>) fell 14.2% to $0.54 in pre-market trading.</li>
<li>OncoCyte Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocx#NASDAQ">OCX</a>) fell 14.1% to $2.33 pre-market trading. Oncocyte announced a transplant assay partnership agreement with Bio-Rad laboratories</li>
<li>&nbsp;</li>
<li>Cyngn Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyn#NASDAQ">CYN</a>) shares fell 13.6% to $0.12 in pre-market trading after declining around 7% on Friday.</li>
<li>SINTX Technologies Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sint#NASDAQ">SINT</a>) fell 12.6% to $0.021 in pre-market trading after declining around 4% on Friday.</li>
<li>&nbsp;</li>
<li>Biophytis SA (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bpts#NASDAQ">BPTS</a>) shares fell 7.4% to $0.31 in pre-market trading.</li>
<li>Polestar Automotive Holding Uk Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/psny#NASDAQ">PSNY</a>) fell 7.2% to $1.35 pre-market trading. On Friday, Cantor Fitzgerald analyst Andres Sheppard reiterated Polestar Automotive with an Overweight and maintained a $5 price target.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/04/38242305/goldman-sachs-likely-to-report-lower-q1-earnings-here-are-the-recent-forecast-changes-from-wall-str"> Goldman Sachs Likely To Report Lower Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street&#39;s Most Accurate Analysts</a>

Pre-Market Outlook

BPTS

MARPS

Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 0.1% on Monday.
The Dow traded up 0.04% to 38,919.32 while the NASDAQ rose 0.11% to 16,266.07. The S&amp;P 500 also rose, gaining, 0.07% to 5,208.09.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/04/38136452/jim-cramer-isnt-going-with-this-tech-company-its-complicated-im-a-nvidia-guy"> Jim Cramer Isn&#39;t Going With This Tech Company: &#39;It&#39;s Complicated. I&#39;m A Nvidia Guy&#39;</a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Consumer discretionary shares jumped by 0.9% on Monday.
In trading on Monday, health care shares fell by 0.3%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
Perion Network Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/peri#NASDAQ">PERI</a>) slashed its FY24 revenue guidance.
Perion Network said it sees first-quarter revenue of $157 million, versus market estimates of $175.53 million. The company said it now expects FY24 revenue of $590 million to $610 million, versus prior outlook of $860 million to $880 million.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
Auddia Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/auud#NASDAQ">AUUD</a>) shares shot up 199% to $4.27 after the company announced the USPTO awarded it with U.S. Patent 11,935,520 for the core AI technology the company uses in its flagship faidr app to deliver ad-free AM/FM radio stations to paid subscribers.
Shares of UTime Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wto#NASDAQ">WTO</a>) got a boost, surging 48% to $0.2738 after the company completed a private placement.
Longeveron Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgvn#NASDAQ">LGVN</a>) shares were also up, gaining 62% to $3.5599 after the company submitted paperwork for a share offering.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Perion Network Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/peri#NASDAQ">PERI</a>) shares dropped 40% to $12.62 after the company slashed FY24 revenue guidance and issued first-quarter outlook below estimates.
Shares of Agenus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agen#NASDAQ">AGEN</a>) were down 18% to $0.4151. Agenus disclosed a 1-for-20 reverse stock split of common stock.
Douglas Dynamics, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/plow#NYSE">PLOW</a>) was down, falling 7% to $22.39. Baird analyst Timothy Wojs downgraded Douglas Dynamics from Outperform to Neutral and lowered the price target from $36 to $25.
Also Check This Out:<a href="https://www.benzinga.com/news/24/04/38141299/this-analyst-with-86-accuracy-rate-sees-more-than-16-upside-in-intel-here-are-5-stock-picks-for-last"> This Analyst With 86% Accuracy Rate Sees More Than 16% Upside In Intel - Here Are 5 Stock Picks For Last Week From Wall Street&#39;s Most Accurate Analysts</a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded down 0.4% to $86.57 while gold traded up 0.6% at $2,358.40.
Silver traded up 1.7% to $27.97 on Monday, while copper rose 1.3% to $4.2920.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares closed mostly higher today. The eurozone&rsquo;s STOXX 600 gained 0.47%, London&rsquo;s FTSE 100 rose 0.41% while Spain&rsquo;s IBEX 35 Index fell 0.04% The German DAX gained 0.79% French CAC 40 climbed 0.72% while Italy&rsquo;s FTSE MIB Index gained 0.90%.
Imports into Germany increased 3.2% month-over-month to EUR 111.5 billion in February, while exports from Germany fell 2% month-over-month to EUR 132.9 billion. German industrial production climbed by 2.1% month-over-month during February.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mixed on Monday, with Japan&rsquo;s Nikkei 225 gaining 0.91%, Hong Kong&rsquo;s Hang Seng Index gaining 0.05%, China&rsquo;s Shanghai Composite falling 0.72% and India&rsquo;s S&amp;P BSE Sensex gaining 0.67%.
Foreign exchange reserves in Singapore increased to SGD 497.3 billion in March from SGD 480.4 billion a month ago. The gauge for Japanese service <a href="https://www.benzinga.com/money/best-sectors-to-invest-in-right-now/">sector</a> declined to 49.8 in March versus 51.3 a month ago. Japan&rsquo;s current account surplus widened to JPY 2,644.2 billion in February from JPY 2,200.3 billion in the year-ago month. Chinese foreign exchange reserves jumped by $19.8 billion to $3.246 trillion during March.
&nbsp;
<h3>Economics</h3>
&nbsp;
There were no major US economic releases Monday.
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/04/38136451/amazon-alphabet-and-a-pharmaceutical-giant-cnbcs-final-trades"> Amazon, Alphabet And A Pharmaceutical Giant: CNBC&#39;s &#39;Final Trades&#39;</a>
&nbsp;

AGEN

AUUD

PERI

PLOW

Gold Moves Higher; Auddia Shares Surge

Longeveron Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGVN#NASDAQ">LGVN</a>) shares traded upwards of 50% Monday after the company announced they submitted paperwork for a share offering and announced CEO Wa&#8217;el Hashad&#8217;s letter to shareholders marking his <a href="https://www.benzinga.com/pressreleases/24/04/g38141004/longeveron-issues-letter-to-shareholders-highlighting-corporate-strategy-clinical-pipeline-and-202">first year anniversary</a>.
The letter to shareholders emphasized its focus on developing Lomecel-B&#x2122; for treating diseases like Hypoplastic Left Heart Syndrome (HLHS) and Alzheimer&#8217;s Disease.The success of their Phase 1 trial for HLHS and ongoing Phase 2 trials was also highlighted. Additionally, the letter discussed progress in Alzheimer&#8217;s research and strategic collaborations for funding. Longeveron plans to optimize resources, pursue partnerships, and enhance manufacturing capabilities. 
Financially, the company said it is seeking additional capital through initiatives like a reverse stock split and registration statement. The company aims to meet operational goals in 2024, including fully enrolling their Phase 2 study for HLHS. They also expressed gratitude to stakeholders and commitment to advancing therapies for patients.
See Also: <a href="https://www.benzinga.com/news/econ-s/24/04/38145762/jamie-dimon-warns-of-stickier-inflation-higher-interest-rates-in-annual-jpmorgan-letter-there-will-b">Jamie Dimon Warns Of Stickier Inflation, Higher Interest Rates In Annual JPMorgan Letter: &#8216;There Will Be Plenty Of Stress&#8217;</a>
<h2 class="wp-block-heading">How To Buy LGVN Stock</h2>
By now you're likely curious about how to participate in the market for Longeveron &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so. 
In the the case of Longeveron, which is trading at $3.44 as of publishing time, $100 would buy you 29.07 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, LGVN has a 52-week high of $44.00 and a 52-week low of $1.83.

Why Longeveron (LGVN) Stock Exploded Higher Today

Offerings

Longeveron Prices $5.25M Public Offering At $2.35/Share

Shares of Agenus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agen#NASDAQ">AGEN</a>) fell sharply during Monday&rsquo;s session.
Agenus disclosed a 1-for-20 reverse stock split of common stock.
Agenus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agen#NASDAQ">AGEN</a>) declined 17% to $0.4181 on Monday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Auddia Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/auud#NASDAQ">AUUD</a>) shares jumped 231.7% to $4.72 after the company announced the USPTO awarded it with U.S. Patent 11,935,520 for the core AI technology the company uses in its flagship faidr app to deliver ad-free AM/FM radio stations to paid subscribers.</li>
<li>Longeveron Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgvn#NASDAQ">LGVN</a>) shares climbed 93.2% to $4.2499 after the company submitted paperwork for a share offering.</li>
<li>UTime Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wto#NASDAQ">WTO</a>) gained 56.8% to $0.29 after the company completed a private placement.</li>
<li>U Power Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ucar#NASDAQ">UCAR</a>) climbed 48% to $6.96 after the company announced announced that its battery-swapping and sharing model for two-wheeled and light four-wheeled electric vehicles is poised for a formal commercial rollout in Wuhu, Anhui Province, China.</li>
<li>Arrowroot Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arrw#NASDAQ">ARRW</a>) rose 38.2% to $19.53.</li>
<li>Destiny Tech100 Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dxyz#NASDAQ">DXYZ</a>) jumped 33.8% to $79.30 after jumping around 77% on Friday.</li>
<li>TechPrecision Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tpcs#NASDAQ">TPCS</a>) rose 29.8% to $4.2837 after the company announced the termination of the agreement to acquire Votaw Precision Technologies.</li>
<li>Adlai Nortye Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/anl#NASDAQ">ANL</a>) gained 27.9% to $10.68.</li>
<li>Connexa Sports Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnxa#NASDAQ">CNXA</a>) surged 26.8% to $0.3801.</li>
<li>AXT, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axti#NASDAQ">AXTI</a>) rose 25.7% to $3.9089. AXT said it sees preliminary revenue of $22.4 million to $22.7 million for the first quarter.</li>
<li>Titan Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttnp#NASDAQ">TTNP</a>) climbed 24.4% to $8.70.</li>
<li>Apartment Income REIT Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/airc#NYSE">AIRC</a>) gained 22.6% to $38.47. Blackstone Real Estate will take AIR Communities private for approximately $10 billion.</li>
<li>GD Culture Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gdc#NASDAQ">GDC</a>) rose 22% to $1.1195.</li>
<li>Outset Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/om#NASDAQ">OM</a>) gained 19.4% to $2.4492. BTIG analyst Maria Thibault initiated coverage on Outset Medical with a Buy rating and announced a price target of $6.</li>
<li>Dogness (International) Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dogz#NASDAQ">DOGZ</a>) gained 18.2% to $9.53.</li>
<li>Galmed Pharmaceuticals Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glmd#NASDAQ">GLMD</a>) rose 17.6% to $0.3999. Last week, Galmed Pharmaceuticals filed annual report on Form 20-F for the fiscal year ended Dec. 31, 2023.</li>
<li>Ducommun Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dco#NYSE">DCO</a>) surged 17.5% to $57.11 after the company confirmed that its Board of Directors received an unsolicited non-binding indication of interest from Albion River LLC.</li>
<li>Mesoblast Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meso#NASDAQ">MESO</a>) rose 13.8% to $6.60.</li>
<li>Perpetua Resources Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ppta#NASDAQ">PPTA</a>) climbed 13.5% to $5.40 after the company announced it received indication for up to $1.8 billion in financing from the Export-Import Bank of the United States for the Stibnite Gold Project.</li>
<li>AltC Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alcc#NASDAQ">ALCC</a>) gained 13.1% to $14.82. Oklo signed a LOI to supply 50 megawatts of power to Diamondback Energy.</li>
<li>WW International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ww#NASDAQ">WW</a>) rose 12.7% to $1.8697.</li>
<li>MicroStrategy Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mstr#NASDAQ">MSTR</a>) gained 10.9% to $1,595.72 amid a rise in Bitcoin.</li>
<li>Model N, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/modn#NYSE">MODN</a>) rose 10.7% to $30.00 after the company announced it will be acquired by Vista Equity Partners for $1.25 billion.</li>
<li>A-Mark Precious Metals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amrk#NASDAQ">AMRK</a>) gained 10.3% to $36.10.</li>
<li>Coinbase Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coin#NASDAQ">COIN</a>) surged 8.1% to $260.41 amid a rise in the price of Bitcoin.</li>
<li>BYND Cannasoft Enterprises Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcan#NASDAQ">BCAN</a>) gained 8% to $1.1119.</li>
<li>Antelope Enterprise Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aehl#NASDAQ">AEHL</a>) shares rose 7.4% to $1.60 after declining 5% on Friday. On April 1, Antelope Enterprise announced preliminary full year 2023 revenue of $70.4 million.</li>
<li>Fastly, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fsly#NASDAQ">FSLY</a>) gained 5.9% to $13.27. Piper Sandler analyst James Fish upgraded Fastly from Neutral to Overweight and lowered the price target from $19 to $16.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>22nd Century Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xxii#NASDAQ">XXII</a>) fell 45.4% to $1.95. 22nd Century Group shares jumped over 140% on Friday after the company signed a new contract manufacturing agreement for the production of branded conventional cigarette products.</li>
<li>Perion Network Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/peri#NASDAQ">PERI</a>) dipped 36% to $13.51 after the company slashed FY24 revenue guidance.</li>
<li>MediaCo Holding Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdia#NASDAQ">MDIA</a>) fell 29.1% to $2.75. Shares of MediaCo Holding jumped 177% on Friday after a 13D amended filing showed Standard General L.P. reported a 95.2% stake in the company as of April 1, 2024.</li>
<li>SuperCom Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spcb#NASDAQ">SPCB</a>) fell 24.3% to $0.2175.</li>
<li>Selina Hospitality PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slna#NASDAQ">SLNA</a>) fell 23.7% to $0.0420.</li>
<li>DatChat, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dats#NASDAQ">DATS</a>) fell 20.5% to $1.16.</li>
<li>HUB Cyber Security Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hubc#NASDAQ">HUBC</a>) dipped 18% to $1.26. HUB Cyber Security recently announced $8 million in financing via a straight debt arrangement.</li>
<li>Agenus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/agen#NASDAQ">AGEN</a>) declined 17% to $0.4181. Agenus disclosed a 1-for-20 reverse stock split of common stock.</li>
<li>TRACON Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcon#NASDAQ">TCON</a>) fell 16.2% to $0.2139.</li>
<li>Conifer Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnfr#NASDAQ">CNFR</a>) dipped 15.9% to $0.8995. Cullen/Frost Bankers is scheduled to host a conference call on Thursday, April 25, 2024 to discuss first quarter 2024 earnings.</li>
<li>HWH International Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hwh#NASDAQ">HWH</a>) fell 15.6% to $1.3408.</li>
<li>Murano Global Investments Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrno#NASDAQ">MRNO</a>) fell 11.8% to $9.79.</li>
<li>Globavend Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gvh#NASDAQ">GVH</a>) shares fell 11.2% to $1.4567 after jumping 57% on Friday.</li>
<li>CCSC Technology International Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cctg#NASDAQ">CCTG</a>) shares fell 11.2% to $3.00 after surging around 28% on Friday.</li>
<li>Reliance Global Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/reli#NASDAQ">RELI</a>) fell 10.8% to $0.4327. Reliance Global, last week, reported FY23 earnings.</li>
<li>ZOOZ Power Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zooz#NASDAQ">ZOOZ</a>) fell 9.5% to $3.6675.</li>
<li>Douglas Dynamics, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/plow#NYSE">PLOW</a>) fell 8.2% to $22.03. Baird analyst Timothy Wojs downgraded Douglas Dynamics from Outperform to Neutral and lowered the price target from $36 to $25.</li>
<li>Trump Media &amp; Technology Group Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/djt#NYSE">DJT</a>) fell 7.4% to $37.60.</li>
<li>Paramount Global (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/para#NASDAQ">PARA</a>) fell 7.1% to $11.12.</li>
<li>Dell Technologies Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dell#NYSE">DELL</a>) fell 4.1% to $127.22.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/24/04/38141299/this-analyst-with-86-accuracy-rate-sees-more-than-16-upside-in-intel-here-are-5-stock-picks-for-last"> This Analyst With 86% Accuracy Rate Sees More Than 16% Upside In Intel - Here Are 5 Stock Picks For Last Week From Wall Street&#39;s Most Accurate Analysts</a>

AEHL

AIRC

ALCC

AMRK

ARRW

AXTI

BCAN

CCTG

CNFR

CONNEXA SPORTS TECH INC by Connexa Sports Technologies Inc.

CNXA

COIN

DATS

DELL

DOGZ

FSLY

GLMD

MDIA

MESO

MODN

MRNO

MSTR

PARA

PPTA

RELI

SLNA

TPCS

TTNP

UCAR

XXII

ZOOZ

Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Longeveron stock rallies 75% amid public offering, business update

ACOR, HUBC and DATS among pre-market losers

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
The trading week starts with a dive into the biggest pre-market stock movers worth keeping tabs on for Monday morning!



Moving stocks this morning are public offerings, delisting notices, dividends and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Hub Cyber Security (NASDAQ:<a href="https://investorplace.com/stock-quotes/hubc-stock-quote/">HUBC</a>) stock is rocketing more than 44% alongside heavy pre-market trading.</li>



<li>Longeveron (NASDAQ:<a href="https://investorplace.com/stock-quotes/lgvn-stock-quote/">LGVN</a>) shares are soaring over 44% after <a href="https://www.nasdaq.com/press-release/longeveron-announces-closing-of-%245.2-million-public-offering-2024-04-11">closing a public offering</a> <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318233823&amp;type=PDF&amp;symbol=LGVN&amp;cdn=a770dc64078369c76023bc924ed74b50&amp;companyName=Longeveron+Inc.&amp;formType=4&amp;formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&amp;dateFiled=2024-04-12">and insider buying</a>.</li>



<li>Allarity Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/allr-stock-quote/">ALLR</a>) stock is surging more than 37% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318232384&amp;type=PDF&amp;symbol=ALLR&amp;cdn=b9395315130771ba262873e0f9f45c59&amp;companyName=Allarity+Therapeutics+Inc.&amp;formType=424B5&amp;formDescription=Prospectus+%5BRule+424%28b%29%285%29%5D&amp;dateFiled=2024-04-12">amending its sales agreement</a>.</li>



<li>Snap One (NASDAQ:<a href="https://investorplace.com/stock-quotes/snpo-stock-quote/">SNPO</a>) shares are rising over 29% after announcing <a href="https://www.nasdaq.com/press-release/resideo-to-acquire-snap-one-to-expand-presence-in-smart-living-products-and">an acquisition deal</a>.</li>



<li>Piedmont Lithium (NASDAQ:<a href="https://investorplace.com/stock-quotes/pll-stock-quote/">PLL</a>) stock is gaining more than 23% after getting <a href="https://www.nasdaq.com/press-release/piedmont-lithium-receives-mining-permit-approval-for-carolina-lithium-2024-04-15">mining permit approval</a>.</li>



<li>SuperCom (NASDAQ:<a href="https://investorplace.com/stock-quotes/spcb-stock-quote/">SPCB</a>) shares are rising over 16% with incredibly strong early morning movement.</li>



<li>Leafly (NASDAQ:<a href="https://investorplace.com/stock-quotes/lfly-stock-quote/">LFLY</a>) stock is flying more than 16% higher after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318232734&amp;type=PDF&amp;symbol=LFLY&amp;cdn=fac5fc6f5ecd43707f276b2f37608568&amp;companyName=Leafly+Holdings+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-04-12">falling Friday on delisting news</a>.</li>



<li>Allakos (NASDAQ:<a href="https://investorplace.com/stock-quotes/allk-stock-quote/">ALLK</a>) shares are increasing over 15% without any clear news this morning.</li>



<li>Medical Properties Trust (NYSE:<a href="https://investorplace.com/stock-quotes/mpw-stock-quote/">MPW</a>) stock is jumping more than 14% after <a href="https://finance.yahoo.com/news/medical-properties-trust-declares-regular-202000224.html">declaring its quarterly dividend</a>.</li>



<li>Marine Petroleum Trust (NASDAQ:<a href="https://investorplace.com/stock-quotes/marps-stock-quote/">MARPS</a>) shares are up over 13% despite a lack of news today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>AudioEye (NASDAQ:<a href="https://investorplace.com/stock-quotes/aeye-stock-quote/">AEYE</a>) stock is plummeting more than 34% on Monday morning.</li>



<li>Neumora Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/nmra-stock-quote/">NMRA</a>) shares are diving over 23% after <a href="https://www.nasdaq.com/press-release/neumora-therapeutics-announces-clinical-hold-of-phase-1-nmra-266-study-2024-04-15">announcing a clinical hold</a> on a Phase 1 trial.</li>



<li>NextPlat (NASDAQ:<a href="https://investorplace.com/stock-quotes/nxpl-stock-quote/">NXPL</a>) stock is tumbling more than 19% <a href="https://investorplace.com/2024/04/why-is-nextplat-nxpl-stock-up-34-today/">following a Friday rally</a>.</li>



<li>Mobile Global Esports (NASDAQ:<a href="https://investorplace.com/stock-quotes/mgam-stock-quote/">MGAM</a>) shares are taking an over 18% beating <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318232971&amp;type=PDF&amp;symbol=MGAM&amp;cdn=16491c2c834a89973f90cd665be062a9&amp;companyName=Mobile+Global+Esports+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-04-12">on delisting news</a>.</li>



<li>IM Cannabis (NASDAQ:<a href="https://investorplace.com/stock-quotes/imcc-stock-quote/">IMCC</a>) stock is sliding more than 17% without any obvious news to report.</li>



<li>Beneficient (NASDAQ:<a href="https://investorplace.com/stock-quotes/benf-stock-quote/">BENF</a>) shares are dropping over 17% on Monday morning.</li>



<li>Tracon Pharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/tcon-stock-quote/">TCON</a>) stock is decreasing more than 13% after warning investors it only has enough cash to operate <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318233346&amp;type=PDF&amp;symbol=TCON&amp;cdn=d702801afb8d5bee35038dce1c2e4efc&amp;companyName=TRACON+Pharmaceuticals+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-04-12">until late Q3 2024</a>.</li>



<li>Cyngn (NASDAQ:<a href="https://investorplace.com/stock-quotes/cyn-stock-quote/">CYN</a>) shares are falling over 13% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318233680&amp;type=PDF&amp;symbol=CYN&amp;cdn=5af092c6fdb596a429dfa66036eafcc1&amp;companyName=Cyngn+Inc.&amp;formType=S-1&amp;formDescription=Registration+statement+under+Securities+Act+of+1933&amp;dateFiled=2024-04-12">proposed public offering</a>.</li>



<li>OncoCyte (NASDAQ:<a href="https://investorplace.com/stock-quotes/ocx-stock-quote/">OCX</a>) stock is slipping more than 12% alongside its <a href="https://finance.yahoo.com/news/oncocyte-reports-full-2023-financial-100000423.html">latest earnings report</a>.</li>



<li>Shuttle Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/shph-stock-quote/">SHPH</a>) shares close out our pre-market stock movers down 12% this morning.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-april-15th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

WIRE, CUTR and USEG are among premarket  gainers

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Longeveron&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/lgvn-stock-quote/">LGVN</a>) stock is up on Monday alongside a couple of pieces of news from the clinical-stage biotechnology company.



First off, investors will note that there&rsquo;s insider buying they need to know about. Several leaders at the company purchased additional shares of LGVN stock recently.



Starting us off is Longeveron CEO Hashad Mohamed Wa&rsquo;el Ahmed. He purchased <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318233823&amp;type=PDF&amp;symbol=LGVN&amp;cdn=a770dc64078369c76023bc924ed74b50&amp;companyName=Longeveron+Inc.&amp;formType=4&amp;formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&amp;dateFiled=2024-04-12">10,638 shares of LGVN stock</a> for a price of $2.35 per share on Thursday. Now he has 19,616 shares of the stock in his direct ownership.



Next is Chief Science Officer Joshua Hare buying <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318233819&amp;type=PDF&amp;symbol=LGVN&amp;cdn=70ef1333b89a880ce6e18adfbbc10d9c&amp;companyName=Longeveron+Inc.&amp;formType=4&amp;formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&amp;dateFiled=2024-04-12">106,383 shares on Wednesday</a> and 42,553 shares on Thursday. He also paid $2.35 each and now has a total of 633,280 directly held by him.



Finally, Board of Director member Rock Soffer bought <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318233822&amp;type=PDF&amp;symbol=LGVN&amp;cdn=49cd8791652dac6334301eb8bfd9edf5&amp;companyName=Longeveron+Inc.&amp;formType=4&amp;formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&amp;dateFiled=2024-04-12">106,383 shares on Wednesday</a> and 31,915 shares on Thursday. He paid $2.35 per share and now directly holds 208,534 units of LGVN stock.



<h2>LGVN Stock Offering Closes</h2>



Investors will also note that LGVN closed out a public offering of its shares last week. This saw it sell 2,234,043 shares combined with warrants for another 2,234,043 shares for $2.35 each. The warrants also have the same exercise price.



Gross proceeds from the offering come to $5.2 million. It will use these funds for the ongoing clinical and regulatory development of Lomecel-B and other corporate purposes.



LGVN stock is up 47.9% as of Monday morning.



Investors will want to keep reading for more of the latest stock market stories!



We have all of the hottest market news worth reading about on Monday! Among that is what has shares of Hub Cyber Security&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/hubc-stock-quote/">HUBC</a>) stock up, the biggest pre-market stock movers this morning and more. All of that info is available below!



<h2>More Stock Market News on Monday</h2>



<ul><li><a href="https://investorplace.com/2024/04/why-is-hub-cyber-security-hubc-stock-up-35-today/">Why Is Hub Cyber Security (HUBC) Stock Up 35% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-april-15th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Monday</a></li>



<li><a href="https://investorplace.com/2024/04/why-do-politicians-want-to-ban-chinese-electric-vehicles-and-what-does-this-mean-for-ev-stocks/">Why Do Politicians Want to Ban Chinese Electric Vehicles? And What Does This Mean for EV Stocks?</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/why-is-longeveron-lgvn-stock-up-48-today/">Why Is Longeveron (LGVN) Stock Up 48% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Longeveron (LGVN) Stock Up 48% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Neumora Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/nmra-stock-quote/">NMRA</a>) stock is falling on Monday after the clinical-stage biopharmaceutical company <a href="https://www.nasdaq.com/press-release/neumora-therapeutics-announces-clinical-hold-of-phase-1-nmra-266-study-2024-04-15">announced a clinical hold</a> on a Phase 1 trial of NMRA-266.



The Food and Drug Administration (FDA) is behind this clinical hold on NMRA-266. the agency enacted this hold after recent pre-clinical data showed convulsions in rabbits. Neumora Therapeutics is working with the FDA to resolve this hold on its trial.



The Phase 1 clinical trial of NMRA-266 has seen 266&nbsp;patients already dosed with the drug. The company notes that there has been no evidence of compulsion in the study. It also says that this latest decision from the FDA makes its previous guidance for the drug&rsquo;s development no longer accurate.



Neumora Therapeutics president and CEO Henry Gosebruch said the following about the FDA hold.




&ldquo;We are disappointed with the unanticipated safety findings in rabbits and are discussing next steps with the FDA. In parallel, we&rsquo;re continuing to make significant progress across the rest of our portfolio as we seek to fulfill our mission to develop medicines for serious brain diseases.&rdquo;




<h2>How This Affects NMRA Stock Today</h2>



NMRA stock is taking a beating on Monday morning with the company&rsquo;s shares down 24.7% as of this writing. That&rsquo;s on top of its shares falling 19.8% year-to-date when markets closed on Friday.



Investors will also keep in mind that NMRA stock isn&rsquo;t seeing much trading today. Only about 39,000 shares have changed hands. The company&rsquo;s daily average trading volume is about 477,000 shares.



There are more stock market stories worth reading about below!



We have all of the hottest stock market news ready to go on Monday! A few examples include why shares of Longeveron&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/lgvn-stock-quote/">LGVN</a>) and Hub Cyber Security&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/hubc-stock-quote/">HUBC</a>) stock are up today as well as the biggest pre-market stock movers this morning. All of that info is available at the following links!



<h2>More Monday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/04/why-is-longeveron-lgvn-stock-up-48-today/">Why Is Longeveron (LGVN) Stock Up 48% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/why-is-hub-cyber-security-hubc-stock-up-35-today/">Why Is Hub Cyber Security (HUBC) Stock Up 35% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-april-15th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Monday</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/why-is-neumora-therapeutics-nmra-stock-down-25-today/">Why Is Neumora Therapeutics (NMRA) Stock Down 25% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Neumora Therapeutics (NMRA) Stock Down 25% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Mobile Global Esports&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/mgam-stock-quote/">MGAM</a>)&nbsp;stock is taking a beating on Monday after the company received <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318232971&amp;type=PDF&amp;symbol=MGAM&amp;cdn=16491c2c834a89973f90cd665be062a9&amp;companyName=Mobile+Global+Esports+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-04-12">a delisting notice</a> from the Nasdaq Exchange.



The Nasdaq Listing Qualifications Staff alerted the company to its shares being delisted due to its closing price being below $1 per share. That means it doesn&rsquo;t meet the minimum bid requirement to remain on the exchange.



Mobile Global Esports was first notified of this issue on April 11, 2023. The company was given 180 trading days to adjust the price issue. After failing to do so, it was granted a 180-day extension.



Unfortunately for MGAM investors, Mobile Global Esports has failed to fix the problem with its share price since then. There&rsquo;s also no option for further extensions to keep it on the Nasdaq Exchange.



<h2>What This Means for MGAM Stock</h2>



Mobile Global Esports says it won&rsquo;t be appealing the delisting decision from the Nasdaq Listing Qualifications Staff. That will result in the company&rsquo;s shares being delisted from the Nasdaq Exchange on Thursday.



Following this, shares of MAGM stock will switch over to the OTC Pink Sheets. It also intends to seek deals with additional market makers to allow for the trading of its shares.



MGAM stock is down 18.4% as of Monday morning. The shares were down 60% year-to-date when markets closed on Friday.



Investors will want to stick around for even more of the most recent stock market stories!



We have all of the hottest stock market news traders need to know about on Monday! That includes what&rsquo;s happening with shares of Neumora Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/nmra-stock-quote/">NMRA</a>) stock, Longeveron&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/lgvn-stock-quote/">LGVN</a>) stock and Hub Cyber Security&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/hubc-stock-quote/">HUBC</a>) stock today. You can catch up on all of these matters at the links below!



<h2>More Stock Market News for Monday</h2>



<ul><li><a href="https://investorplace.com/2024/04/why-is-neumora-therapeutics-nmra-stock-down-25-today/">Why Is Neumora Therapeutics (NMRA) Stock Down 25% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/why-is-longeveron-lgvn-stock-up-48-today/">Why Is Longeveron (LGVN) Stock Up 48% Today?</a></li>



<li><a href="https://investorplace.com/2024/04/why-is-hub-cyber-security-hubc-stock-up-35-today/">Why Is Hub Cyber Security (HUBC) Stock Up 35% Today?</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/why-is-mobile-global-esports-mgam-stock-down-18-today/">Why Is Mobile Global Esports (MGAM) Stock Down 18% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Mobile Global Esports (MGAM) Stock Down 18% Today?

Longeveron stock rallies pre-market on Alzheimer's data update

Longeveron stock rallies 85% on Alzheimer's presentation (update)

BSGM, ENLV and WISA among mid-day movers

ACOR

ALLK

BENF

BROG

CISS

CRON

ENLV

GCTS

HUSA

INCR

INDO

INMD

LFLY

LUXH

MAXN

MGAM

NEOV

PRZO

SANG

SHPH

SSNT

VINC

VIRX

WAVE

WISA

YYAI

ZJYL

Health Care

Longeveron Announces Closing of $2.36 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

-

-

-

-

-

-

-

25% Off Benzinga's Most Powerful Trading Tools

-

-

-

-

-

-

-

Longeveron Stock (NASDAQ:LGVN), Trade Ideas